Data
Markets
Stocks
Indices
Events Calendar
Economy
Economic Indicators
Economic Calendar
Funds
Mutual Funds
ETFs
CEFs
Featured Content
Economic Summary Deck
Economic Summary Deck
Fund Flows by Category
Sector & Industry Data
Tools
Monitor
Dashboard
Watchlists
Alerts
News
Visualize
Fundamental Chart
Scatter Plot
Technical Chart
Report
Report Builder
Talking Points
Email Reports
Research
Stock Screener
Fund Screener
Comp Tables
Timeseries Analysis
Excel
Sectors
Investment Strategies
Manage
Portfolios
Custom Securities
Scenarios
Portfolio Optimizer
Featured Content
Best Performing Mutual Funds of the Last 10 Years
Best Performing Mutual Funds of the Last 10 Years
Dollar-Cost Averaging Scenario
Explore Investment Strategies
Support
Resources
Tutorials
FAQs
Integrations
Financial Glossary
Info
About Us
Contact Us
Product Release Notes
Content
Webinars
Case Studies
Insights & Visuals
Blog
Featured Content
Fund Flows Report
Fund Flows Report
Advisor-Client Communication Survey
YCharts University Training Sessions
Plans
Cancel
Free Trial
Log In

Merck & Co Inc (MRK)

88.11 +0.24 (+0.27%) USD  |  NYSE  |  Mar 26, 16:00
88.25 +0.14 (+0.16%) Pre-Market: 08:00
Reports
 Actions
Notes
Add to Watchlist
More

Merck Monthly Value at Risk (VaR) 5% (5Y Lookback)

View 4,000+ Financial Data Types:
Add
Browse

Monthly Value at Risk (VaR) 5% (5Y Lookback) Chart

View Monthly Value at Risk (VaR) 5% (5Y Lookback) for MRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Monthly Value at Risk (VaR) 5% (5Y Lookback) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Value At Risk (VaR) Definition

View Value At Risk (VaR) Definition
Start Trial

The VaR calculates the potential loss of an investment with a given time frame and confidence level.

Read full definition.

Monthly Value at Risk (VaR) 5% (5Y Lookback) Range, Past 5 Years

View Monthly Value at Risk (VaR) 5% (5Y Lookback) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Monthly Value at Risk (VaR) 5% (5Y Lookback) Benchmarks

View Monthly Value at Risk (VaR) 5% (5Y Lookback) Benchmarks
Start Trial
Amgen Inc Upgrade
Gilead Sciences Inc Upgrade
Johnson & Johnson Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Moderna Inc Upgrade

Monthly Value at Risk (VaR) 5% (5Y Lookback) Related Metrics

Alpha (5Y) Upgrade
Beta (5Y) Upgrade
Annualized Standard Deviation of Monthly Returns (5Y Lookback) Upgrade
Historical Sharpe Ratio (5Y) Upgrade
Historical Sortino (5Y) Upgrade
Max Drawdown (5Y) Upgrade
Quickflows
MRK
Settings